ELRIG is pleased to invite you to the 5th Annual Research & Innovation Meeting and its new location at Homerton College, in Cambridge, UK on 29th and 30th March, 2017. Building on the success of the meeting in previous years, this year will be a larger, 2-day event that will provide expanded scientific tracks, a larger exhibition and greater networking opportunities with the UK’s most innovative life science companies.
Plenary Keynote Speakers
Investment Committee Chair at Apollo Therapeutics
VP and General Manager at Corning Life Sciences
- Single cell analysis including transcriptomics, NGS, micro-fluidics
- Physiologically relevant 3D models & scale-up
The meeting will bring together world class speakers and leading academic and industry experts who will discuss the challenges and opportunities for cells as models of disease to improve the success of drug discovery and to develop new therapeutic agents. Hear up-to-date views on this exciting and rapidly evolving area, including presentations on the latest advances and technology breakthroughs.
Each year, Research & Innovation provides a highly impactful learning and networking opportunity for scientists engaged in early-phase drug discovery whether in Academia, Biotech or Pharma. Scientific sessions are complemented by a poster session, networking opportunities and a vendor exhibition with over 40 exhibitors, including recently formed companies with new and disruptive technologies. This meeting will facilitate new ideas and potentiate the cellular models field as it expands into new areas of research and discovery.
Join us for this must-attend event to learn about new state-of-the-art technologies and the latest research and innovation trends in drug discovery!
Immune therapies have had a major impact in the treatment of many human diseases, from early discoveries of bacterial cell wall components as vaccine adjuvants and corticosteroids for the treatment and prevention of asthma, through to the development of specific monoclonal antibodies which have revolutionised the treatment of rheumatoid arthritis and psoriasis. Despite advances in the development of immunotherapies, many patients with immune-mediated diseases still do not have their disease well controlled and there is a continuing need for better treatments. Our greatest challenges are to understand at a cellular and molecular level the mechanisms which control the innate and adaptive immune response in health and disease, and to use these findings to identify safer and more effective medicines.
In this track, scientists from academia and industry will present advances in target and disease biology and we will see examples of how these findings can be applied to develop next generation immune therapy drugs.
Immuno-therapy is revolutionising the way we approach treatment for cancer. A greater understanding of the complex interactions and combinations of responses has enabled modern drug discovery to unlock new therapies and many more new opportunities in this field. This track will present the latest science from leading opinion leaders that will help you understand the latest developments and build on these opportunities.
Single cell analysis including transcriptomics, NGS, micro-fluidics
For many years the ability to measure single cells has promised to change how we understand their biology and potential to be modified by medicines. Having techniques that enable us to understand every single cell and how they interact with each other is becoming increasingly important. Novel cell models presents an opportunity to advance drug discovery and development. This track will bring together the industrial and academic experts that are now using these technologies to change the way study biology and find new therapeutics.
Physiologically relevant 3D models & scale-up
Cellular science has played a pivotal role in both fundamental research and drug discovery for over a century. Throughout this period, great advances have been made in how cells are cultured and manipulated in vitro so as to provide models as physiologically relevant as possible. Consequently, whole tissue and 3-dimensional (D) cell culture technologies are being rapidly adopted in vitro as a means to better mimic in vivo settings. Emerging data using these technologies is increasing our understanding of cellular viability and growth, differentiation and signaling in spheroid, organoid or tissue assemblies, thereby providing a better understanding of physiological and pathophysiological processes and, ultimately, underpinning new approaches for optimizing the development of new therapies.
In this session, speakers from leading academic and pharmaceutical institutions will cover established and emerging aspects of whole tissue culture, with a focus on innovative approaches in basic cellular and tissue physiology that are applicable to, or being utilized, in translational research and drug discovery arenas.
Mike Kerins, Cambridge Bioscience
Mark Wigglesworth, AstraZeneca
Stuart Farrow, Cancer Research Technology
Rahul Roychoudhuri, Babraham Institute
Track: Single cell analysis including transcriptomics, NGS, micro-fluidics
Frank Craig, Sphere Fluidics
Bertie Gottgens, Cambridge Stem Cell Institute
Peter Morley, GlaxoSmithKline
Rachel Chambers, UCL
Track: Physiologically relevant 3D models & scale-up
Margaret Ashcroft, University of Cambridge
Richard Eglen, Corning
For Poster Presenters
Poster presentations at Research & Innovation 2017 are an excellent opportunity for delegates to network with colleagues and communicate their research FREE OF CHARGE. To be considered for a poster presentation, you must first submit an abstract for review by the meeting’s Scientific Program Committee.
For those wishing to participate, a subset of abstracts will also be considered for a short, poster taster session involving a 10 minute oral presentation within the main Symposia sessions. Decisions regarding acceptance of poster abstracts and/or selection for Poster Tasters will be communicated via e-mail at the end of February.
Deadlines for Submission:
28th February 2016: Poster Taster Spot
17th March 2016: General Poster Submission
All presenters must be registered as full-conference attendees in order to present at Research & Innovation.
Poster size should be no larger than A0 Portrait (W: 841mm x H: 1189mm).
ELRIG organizers will provide supplies to mount your posters, including Velcro and/or pushpins.
We apologise that we are unable to accommodate posters which are any larger than A0 Portrait.
Posters from Exhibiting Companies:
As an exhibitor, you have one poster spot included with your stand package.
Additional poster spots are £250 +VAT each.
Posters from Non-Exhibiting Companies:
Non-exhibiting vendor companies will be charged £250 +VAT for each poster submitted.
The speaker’s reception will take place on Tuesday 28th March 2017 with drinks at 7.30 and buffet from 8pm. The reception venue is:
University of Cambridge
Directions & Parking
How to Get to Homerton College:
Stansted Airport: 28 miles, 54 minutes by train
Gatwick Airport: 92 miles, 125 minutes by train
Heathrow Airport: 70 miles, 135 minutes by train
It is a 15-minute walk from the Station to Homerton College (0.8 miles).
On exiting the station turn left onto Station Place and walk for a few minutes before turning right on to Brookgate. Turn left by the Co-op on to Hills Road and walk over the railway bridge, continue walking along Hills Road and cross over Cherry Hinton Road at the lights. Homerton College is on the right-hand side past Hills Road Sixth Form, behind the black railings. Follow the signs “to the Porters’ Lodge” to the Conference Centre Reception.
From the M11
Exit the motorway at junction 11, following signs to City Centre. Continue along the A1309 through Trumpington, past the Green Man pub and turn right at the junction and traffic lights on to Long Road. At the cross road, turn left onto Hills Road and continue for approximately ½ a mile.
You will see Homerton College signposted on the left, behind the black railings. This is the PORTERS lodge location. Just beyond the main College building, turn left into Harrison drive and follow signs for Homerton Conference Centre car park, the entrance for which is at the back of the site.
From the City Centre:
Follow the A1307 out the City Centre, eventually crossing over the railway bridge. At the junction go straight across and turn right into Harrison Drive and follow signs for Homerton Conference Centre car park, the entrance for which is at the back of the site.
There are 140 spaces at the rear of Homerton Conference Centre which is free of charge for conference delegates (this is located at the end of Harrison Drive. Follow the road all the way round the back of Harrison House. Please see the attached site plan). Space is not guaranteed and is available on a first come first served basis. Alternative Parking is available at Cambridge Leisure Park.
Car Park Code: Key in the code 1610 at the barrier.